Back to Search Start Over

Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol)

Authors :
Elodie Fiot
Bertille Alauze
Bruno Donadille
Dinane Samara-Boustani
Muriel Houang
Gianpaolo De Filippo
Anne Bachelot
Clemence Delcour
Constance Beyler
Emilie Bois
Emmanuelle Bourrat
Emmanuel Bui Quoc
Nathalie Bourcigaux
Catherine Chaussain
Ariel Cohen
Martine Cohen-Solal
Sabrina Da Costa
Claire Dossier
Stephane Ederhy
Monique Elmaleh
Laurence Iserin
Hélène Lengliné
Armelle Poujol-Robert
Dominique Roulot
Jerome Viala
Frederique Albarel
Elise Bismuth
Valérie Bernard
Claire Bouvattier
Aude Brac
Patricia Bretones
Nathalie Chabbert-Buffet
Philippe Chanson
Regis Coutant
Marguerite de Warren
Béatrice Demaret
Lise Duranteau
Florence Eustache
Lydie Gautheret
Georges Gelwane
Claire Gourbesville
Mickaël Grynberg
Karinne Gueniche
Carina Jorgensen
Veronique Kerlan
Charlotte Lebrun
Christine Lefevre
Françoise Lorenzini
Sylvie Manouvrier
Catherine Pienkowski
Rachel Reynaud
Yves Reznik
Jean-Pierre Siffroi
Anne-Claude Tabet
Maithé Tauber
Vanessa Vautier
Igor Tauveron
Sebastien Wambre
Delphine Zenaty
Irène Netchine
Michel Polak
Philippe Touraine
Jean-Claude Carel
Sophie Christin-Maitre
Juliane Léger
Source :
Orphanet Journal of Rare Diseases, Vol 17, Iss S1, Pp 1-39 (2022)
Publication Year :
2022
Publisher :
BMC, 2022.

Abstract

Abstract Turner syndrome (TS; ORPHA 881) is a rare condition in which all or part of one X chromosome is absent from some or all cells. It affects approximately one in every 1/2500 liveborn girls. The most frequently observed karyotypes are 45,X (40–50%) and the 45,X/46,XX mosaic karyotype (15–25%). Karyotypes with an X isochromosome (45,X/46,isoXq or 45,X/46,isoXp), a Y chromosome, X ring chromosome or deletions of the X chromosome are less frequent. The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) is to provide health professionals with information about the optimal management and care for patients, based on a critical literature review and multidisciplinary expert consensus. The PNDS, written by members of the French National Reference Center for Rare Growth and Developmental Endocrine disorders, is available from the French Health Authority website. Turner Syndrome is associated with several phenotypic conditions and a higher risk of comorbidity. The most frequently reported features are growth retardation with short adult stature and gonadal dysgenesis. TS may be associated with various congenital (heart and kidney) or acquired diseases (autoimmune thyroid disease, celiac disease, hearing loss, overweight/obesity, glucose intolerance/type 2 diabetes, dyslipidemia, cardiovascular complications and liver dysfunction). Most of the clinical traits of TS are due to the haploinsufficiency of various genes on the X chromosome, particularly those in the pseudoautosomal regions (PAR 1 and PAR 2), which normally escape the physiological process of X inactivation, although other regions may also be implicated. The management of patients with TS requires collaboration between several healthcare providers. The attending physician, in collaboration with the national care network, will ensure that the patient receives optimal care through regular follow-up and screening. The various elements of this PNDS are designed to provide such support.

Details

Language :
English
ISSN :
17501172
Volume :
17
Issue :
S1
Database :
Directory of Open Access Journals
Journal :
Orphanet Journal of Rare Diseases
Publication Type :
Academic Journal
Accession number :
edsdoj.47d7e0d1bd19414b82a3ff48728cebb1
Document Type :
article
Full Text :
https://doi.org/10.1186/s13023-022-02423-5